Patients with end-stage age-related macular degeneration (AMD) will soon have a therapeutic option they've never had before – an implantable miniature telescope developed by VisionCare Ophthalmic Technologies (Saratoga, California). The FDA said it has approved the device to improve vision in some patients with end-stage AMD. (Medical Device Daily) Read More
